Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SIVB
5151
PUT
DELISTED
SVB Financial Group
SIVB
| $112K | ﹤0.01% |
1,300
+300
| +30% | +$25.9K |
2013 Q2
1 quarter
|
|
|
RTI
5152
CALL
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $112K | ﹤0.01% |
3,500
-800
| -19% | -$24.9K |
2013 Q2
1 quarter
|
|
|
ASRT
5153
DELISTED
Assertio
ASRT
| $111K | ﹤0.01% |
247
+85
| +52% | +$34.7K |
2013 Q2
1 quarter
|
|
5154
PUT
Astec Industries
ASTE
$967M
| $111K | ﹤0.01% |
3,100
+3,000
| +3,000% | +$107K |
2013 Q2
1 quarter
|
|
5155
PUT
BCE
BCE
$18.4B
| $111K | ﹤0.01% |
2,600
-10,300
| -80% | -$429K |
2013 Q2
1 quarter
|
|
5156
Lattice Semiconductor
LSCC
$19B
| $111K | ﹤0.01% |
24,869
-3,629
| -13% | -$18K |
2013 Q2
1 quarter
|
|
5157
CALL
Pegasystems
PEGA
$5.58B
| $111K | ﹤0.01% |
11,200
+4,400
| +65% | +$40.2K |
2013 Q2
1 quarter
|
|
|
CLGX
5158
PUT
DELISTED
Corelogic, Inc.
CLGX
| $111K | ﹤0.01% |
4,100
-2,000
| -33% | -$53.7K |
2013 Q2
1 quarter
|
|
|
HGT
5159
CALL
DELISTED
Hugoton Royalty Trust
HGT
| $111K | ﹤0.01% |
14,800
+11,400
| +335% | +$94.8K |
2013 Q2
1 quarter
|
|
|
IFT
5160
DELISTED
IMPERIAL HLDGS INC COM STK (FL)
IFT
| $111K | ﹤0.01% |
+17,476
| New | +$120K |
2013 Q3
0 quarters
|
|
|
COCO
5161
DELISTED
CORINTHIAN COLLEGES INC
COCO
| $111K | ﹤0.01% |
50,668
+14,488
| +40% | +$33.6K |
2013 Q2
1 quarter
|
|
|
REV
5162
DELISTED
Revlon, Inc.
REV
| $111K | ﹤0.01% |
4,005
-17,766
| -82% | -$439K |
2013 Q2
1 quarter
|
|
5163
Angi Inc
ANGI
$245M
| $110K | ﹤0.01% |
487
-1,513
| -76% | -$352K |
2013 Q2
1 quarter
|
|
5164
CALL
Brookfield Infrastructure Partners
BIP
$16.8B
| $110K | ﹤0.01% |
7,308
-5,292
| -42% | -$76.8K |
2013 Q2
1 quarter
|
|
5165
CALL
eHealth
EHTH
$21.5M
| $110K | ﹤0.01% |
3,400
+900
| +36% | +$24.8K |
2013 Q2
1 quarter
|
|
5166
Globe Life
GL
$12.7B
| $110K | ﹤0.01% |
+2,276
| New | +$107K |
2013 Q3
0 quarters
|
|
5167
CALL
Huron Consulting
HURN
$2.58B
| $110K | ﹤0.01% |
2,100
+1,500
| +250% | +$73.9K |
2013 Q2
1 quarter
|
|
5168
CALL
Portland General Electric
POR
$5.24B
| $110K | ﹤0.01% |
3,900
-100
| -3% | -$2.99K |
2013 Q2
1 quarter
|
|
|
NUVA
5169
CALL
DELISTED
NuVasive, Inc.
NUVA
| $110K | ﹤0.01% |
4,500
-5,500
| -55% | -$135K |
2013 Q2
1 quarter
|
|
|
CSII
5170
PUT
DELISTED
Cardiovascular Systems, Inc.
CSII
| $110K | ﹤0.01% |
+5,500
| New | +$114K |
2013 Q3
0 quarters
|
|
|
UMPQ
5171
PUT
DELISTED
Umpqua Holdings Corp
UMPQ
| $110K | ﹤0.01% |
6,800
+5,100
| +300% | +$84.1K |
2013 Q2
1 quarter
|
|
|
GHDX
5172
CALL
DELISTED
Genomic Health, Inc.
GHDX
| $110K | ﹤0.01% |
3,600
-13,800
| -79% | -$462K |
2013 Q2
1 quarter
|
|
|
EPB
5173
PUT
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
| $110K | ﹤0.01% |
2,600
-2,200
| -46% | -$92.9K |
2013 Q2
1 quarter
|
|
|
MCRS
5174
PUT
DELISTED
MICROS SYSTEMS INC
MCRS
| $110K | ﹤0.01% |
2,200
-2,200
| -50% | -$107K |
2013 Q2
1 quarter
|
|
|
FURX
5175
CALL
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $110K | ﹤0.01% |
2,500
+1,300
| +108% | +$53.8K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.